What can we learn from large scale COPD studies?

J. Vestbo (Odense, Denmark)

Source: Annual Congress 2013 –ME6 What can we learn from large scale COPD studies?
Session: ME6 What can we learn from large scale COPD studies?
Session type: Meet the expert
Number: 2962
Disease area: Airway diseases

PDF journal article, handout or slidesMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Vestbo (Odense, Denmark). What can we learn from large scale COPD studies?. Annual Congress 2013 –ME6 What can we learn from large scale COPD studies?

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
How to define asthma in large-scale studies?
Source: International Congress 2014 – Is asthma prevalence still increasing?
Year: 2014

What have we learn from rebiospy studies?
Source: ERS Research Seminar
Year: 2015

What can we learn from paediatric cohort studies?
Source: International Congress 2018 – Paediatric Year in Review
Year: 2018

Large trials, new knowledge: the changing face of COPD management
Source: Eur Respir J 2015; 45: 1692-1703
Year: 2015

Can epidemiological studies determine the productivity-related burden of COPD?
Source: Eur Respir J, 50 (3) 1701515; 10.1183/13993003.01515-2017
Year: 2017

What makes large epidemiological studies comparable?
Source: Eur Respir J 2010; 36: 720-721
Year: 2010

What can we learn from models to study exacerbation mechanisms in asthma and COPD?
Source: Annual Congress 2010 - Severe exacerbations in asthma and COPD: new causes, mechanisms and models of care
Year: 2010

COPD: time to improve its taxonomy?
Source: ERJ Open Res, 4 (1) 00132-2017; 10.1183/23120541.00132-2017
Year: 2018

What do patients with COPD need to know?
Source: Eur Respir J 2003; 22: Suppl. 45, 168s
Year: 2003

How does EQ-5D-5L perform in asthma patients?
Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness
Year: 2019

Is the question ² how is your asthma doing? ² sufficient to assess asthma control in primary care?
Source: Eur Respir J 2004; 24: Suppl. 48, 269s
Year: 2004

What features do patients and clinicians ‘want’ in the future Internet-Of-Things (IoT) systems for asthma: a mixed method study
Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine
Year: 2020

What can ILD registries teach us?
Source: Virtual Congress 2021 – Interstitial lung diseases
Year: 2021

Real-life COPD patients compared to large trial populations: An UNLOCK external validity study
Source: Annual Congress 2013 –Management of respiratory diseases in primary care
Year: 2013

Is the whole body vibration able to improve functional capacity in patients with COPD? A meta-analysis
Source: International Congress 2015 – Rehabilitation, exercise, hospitalisation and COPD
Year: 2015

Are asthma symptom intensity scales better than biomarkers for diagnosing asthma? A prospective observational study
Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Year: 2021

It is time to further expand research in tailoring self-management of COPD exacerbations!
Source: Eur Respir J, 55 (1) 1902225; 10.1183/13993003.02225-2019
Year: 2020

What can we learn about COPD from single-cell genomics?
Source: International Congress 2019 – The Human Lung Cell Atlas
Year: 2019

Asthma quality of life in clinical trials - can we combine data from different countries?
Source: Eur Respir J 2001; 18: Suppl. 33, 4s
Year: 2001